Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Insider Filings

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Jul 20, 2022 6:59pm

67 Views

Post# 34838758

RE:RE:RE:Insider Filings

I thought it was strange that they coded Littlejohn's purchase of grants differently than Trudeau. At first glance, it did look like like a direct acquisition by Littlejohn.

SPCEO1 wrote: While it is better than nothing, it is pretty close to nothing since it appears these transactions are just grants of shares to these two directors, not purchases they made with their own money. Hopefully, we will see some of that too in the next few days.

SABBOBCAT wrote: THIS! This is important. Small purchases, but they send a message. Hopefully others follow suit. This is what I have been waiting to see to prove the stories arent full of hot air.

archeo753 wrote:

Filed 2022-07-20 08:18

Tx date 2022-07-19 $TH
Theratechnologies Inc. Littlejohn, Gary Peter
4 - Director of Issuer

Direct Ownership

Units d'actions diffres (DSU)
30 - Acquisition or disposition under a purchase/ownership plan $15,000
+5,396 vol
$2.78 each 21,156

Filed 2022-07-19 20:37

Tx date 2022-07-19 $TH
Theratechnologies Inc. TRUDEAU, ALAIN
4 - Director of Issuer

Direct Ownership

Units d'actions diffres (DSU)
56 - Grant of rights $15,000
+5,396 vol
$2.78 each 28,437

Filed 2022-07-20 08:18 Tx date 2022-07-19	$TH Theratechnologies Inc.	Littlejohn, Gary Peter 4 - Director of Issuer Direct Ownership	Units d'actions diffres (DSU) 30 - Acquisition or disposition under a purchase/ownership plan	$15,000 +5,396 vol $2.78 each	21,156
Filed 2022-07-19 20:37 Tx date 2022-07-19	$TH Theratechnologies Inc.	TRUDEAU, ALAIN 4 - Director of Issuer Direct Ownership	Units d'actions diffres (DSU) 56 - Grant of rights	$15,000 +5,396 vol $2.78 each	28,437